These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11418729)

  • 21. Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant.
    Goldman SL; Bosque E; McCann E; Lewis K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S25-8. PubMed ID: 1735847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On surfactant replacement therapy with Exosurf.
    Courtney SE
    Pediatr Pulmonol; 1992 May; 13(1):60-1. PubMed ID: 1589317
    [No Abstract]   [Full Text] [Related]  

  • 23. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
    Pfenninger J; Aebi C; Bachmann D; Wagner BP
    Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tracheal aspirate surface tension in babies with hyaline membrane disease: effects of synthetic surfactant replacement.
    McMillan DD; Singhal N; Shukla AK; Schürch S
    Pediatr Pulmonol; 1998 Sep; 26(3):173-82. PubMed ID: 9773912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V; Schumacher RE
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary haemorrhage in low-birthweight babies.
    Majeed-Saidan MA; al-Hifzi I; Khan M
    Lancet; 1993 Jan; 341(8837):120. PubMed ID: 8093391
    [No Abstract]   [Full Text] [Related]  

  • 27. Congenital diaphragmatic hernia.
    Fitzsimons R; Piracha M
    Ir Med J; 1995; 88(1):34. PubMed ID: 7737842
    [No Abstract]   [Full Text] [Related]  

  • 28. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seizures after inadvertent umbilical venous infusion of synthetic surfactant (Exosurf): cause or coincidence?
    Frey B; Keller E; Losa M
    Eur J Pediatr; 1999 Jul; 158(7):610. PubMed ID: 10412829
    [No Abstract]   [Full Text] [Related]  

  • 30. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
    Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
    [No Abstract]   [Full Text] [Related]  

  • 31. Aerosolized surfactant in sepsis-induced adult respiratory distress syndrome.
    Doig C
    JAMA; 1995 Apr; 273(16):1259-60. PubMed ID: 7715036
    [No Abstract]   [Full Text] [Related]  

  • 32. Results of laboratory surveillance of very low birth weight infants treated with a synthetic surfactant.
    Bose C; Corbet A; Bose G; Prats JG; Russell L; Edwards K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S13-7. PubMed ID: 1735845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebulized synthetic surfactant in reperfusion injury after single lung transplantation.
    Strüber M; Cremer J; Harringer W; Hirt SW; Costard-Jäckle A; Haverich A
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):563-4. PubMed ID: 7637383
    [No Abstract]   [Full Text] [Related]  

  • 34. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS; Ewing CK; Richards T; Taeusch HW
    J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of ARDS with two doses of synthetic surfactant.
    Heikinheimo M; Hynynen M; Rautiainen P; Andersson S; Hallman M; Kukkonen S
    Chest; 1994 Apr; 105(4):1263-4. PubMed ID: 8162762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits.
    Sherman MP; Campbell LA; Merritt TA; Long WA; Gunkel JH; Curstedt T; Robertson B
    J Pediatr; 1994 Dec; 125(6 Pt 1):939-47. PubMed ID: 7996369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of institutional differences on study of surfactant in two centers.
    Etches PC; Peliowski A; Finer NN; Tierney AJ
    J Pediatr; 1991 Jul; 119(1 Pt 1):162-3. PubMed ID: 2066853
    [No Abstract]   [Full Text] [Related]  

  • 38. The acute respiratory distress syndrome.
    Matthay MA
    N Engl J Med; 1996 May; 334(22):1469-70. PubMed ID: 8618587
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
    Levine D; Edwards DK; Merritt TA
    AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
    Sandberg KL; Lindstrom DP; Sjöqvist BA; Parker RA; Cotton RB
    Pediatr Pulmonol; 1997 Nov; 24(5):337-43. PubMed ID: 9407567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.